Treating diseases in the eye requires precise products containing high-quality ingredients and thorough testing to ensure passing sterility and endotoxin limits, which is why Retinologists and Ophthalmologists find confidence in quality securing their custom solutions from Compound Preferred. Our aliquoting service ensures a reduction in waste through small hand-crafted batches, cost savings and overall quality solutions.

Utilizing our custom solutions enhance:


  • Competitive Pricing
  • Subscription Service
  • Price Breaks for Bulk Orders


  • Sterility and endotoxin testing per FDA requirements
  • ISO 5 Compounding Area
  • ISO 7, 8 Rooms
  • Adherence to all cGMP Standards

The primary products we supply to Retinologists/Ophthalmologists are Avastin® (Bevacizumab) and MVASI™ (Bevacizumab-awwb), a biosimilar for Avastin®.

According to the American Academy of Ophthalmology, Avastin® is used to treat:
  • Wet age-related macular degeneration (AMD)
  • Swelling of the retina (macular edema)
  • Diabetic retinopathy
  • Retinal vein occlusion

Avastin® (Bevacizumab)

MVASI™ (Bevacizumab-awwb)

Become a Partner

We specialize in custom solutions, aliquoting and shortages. We are already helping many customers by providing custom-unit dosing options that previously haven’t been offered from other 503B facilities. These custom options have allowed our current clients to reduce medication waste and ultimately save money.